Document is current

Article History

Received: 1 November 2023

Accepted: 11 December 2023

First Online: 17 January 2024

Declarations

:

: Ms. Emily A. Walsh, Dr. Kathryn Post, Ms. Katina Massad, Ms. Nora Horick, Dr. Ann H. Partridge, Dr. Elyse R. Park, and Dr. Jennifer S. Temel: no conflicts of interest or financial interests. Dr. Michael H. Antoni: paid consultant for Blue Note Therapeutics and Atlantis Healthcare. Co-inventor of cognitive behavioral stress management, filed as IP with the University of Miami (UMIP-483), which is licensed to Blue Note Therapeutics. Dr. Frank J. Penedo: paid consultant of Blue Note Therapeutics, received payment from the University of Texas San Antonio Health Sciences Center. Dr. Steven A. Safren: Royalties from books with Oxford University Press, Guilford Publications, and Springer/Humana Press. Dr. Jeffrey Peppercorn: Financial compensation from Abbott Labs and reports spousal employment at GlaxoSmithKline. Dr. Joseph A. Greer: Paid consultant for BeiGene, research funding from Blue Note Therapeutics, royalties for an edited book from Oxford University Press. Dr. Jamie M. Jacobs: Prior financial interest in VivorCare, Inc. (reviewed and managed by MGH and Mass General Brigham), consultant for VivorCare, Inc.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all participants included in the study.

: Not applicable.